Foresite Capital Management IV LLC insider trades

Open-market stock purchases and sales by Foresite Capital Management IV LLC, 10% Owner at Eikon Therapeutics, Inc, from SEC Form 4 filings since Nov 7, 2019.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -50%.

Recent trades

DateStockTradeValue
Feb 4, 2026EIKN Eikon Therapeutics, IncBought (not open market)—
Feb 4, 2026EIKN Eikon Therapeutics, IncBought (not open market)—
Feb 4, 2026EIKN Eikon Therapeutics, IncBought (not open market)—
Feb 4, 2026EIKN Eikon Therapeutics, IncBought (not open market)—
Feb 4, 2026EIKN Eikon Therapeutics, IncBought (not open market)—
Feb 4, 2026EIKN Eikon Therapeutics, IncBought (not open market)—
Feb 4, 2026EIKN Eikon Therapeutics, IncBought (not open market)—
Feb 4, 2026EIKN Eikon Therapeutics, IncBought (not open market)—
Feb 4, 2026EIKN Eikon Therapeutics, IncBought (not open market)—
Feb 4, 2026EIKN Eikon Therapeutics, IncBought (not open market)—
Feb 4, 2026EIKN Eikon Therapeutics, IncBought$1M
Feb 4, 2026EIKN Eikon Therapeutics, IncBought (not open market)—
Feb 4, 2026EIKN Eikon Therapeutics, IncBought (not open market)—
Feb 4, 2026EIKN Eikon Therapeutics, IncBought (not open market)—
Feb 4, 2026EIKN Eikon Therapeutics, IncBought (not open market)—
Feb 4, 2026EIKN Eikon Therapeutics, IncBought (not open market)—
Feb 4, 2026EIKN Eikon Therapeutics, IncBought (not open market)—
Feb 4, 2026EIKN Eikon Therapeutics, IncBought (not open market)—
Feb 4, 2026EIKN Eikon Therapeutics, IncBought (not open market)—
Feb 4, 2026EIKN Eikon Therapeutics, IncBought (not open market)—
Feb 4, 2026EIKN Eikon Therapeutics, IncBought (not open market)—
Feb 4, 2026EIKN Eikon Therapeutics, IncBought (not open market)—
Feb 4, 2026EIKN Eikon Therapeutics, IncBought (not open market)—
Feb 4, 2026EIKN Eikon Therapeutics, IncBought (not open market)—
Feb 4, 2026EIKN Eikon Therapeutics, IncBought (not open market)—

Companies traded

  • EIKN Eikon Therapeutics, Inc: 1 buy, last Feb 4, 2026
  • KNTE Kinnate Biopharma Inc: 2 buys, last Apr 3, 2024
  • AERI Aerie Pharmaceuticals Inc: other filings, last Dec 20, 2019

Get free alerts when Foresite Capital Management IV LLC files a new trade →